Certificate

Brand

Panagene

Product Type

Reagents

Highlights

The PANA RealTyper™ HPV Screening Kit is an in vitro diagnostic reagent for detecting of human papilloma virus (HPV) from common specimen type, cervical swab and liquid based cytology (LBC) sample.

The PANA RealTyper™ HPV Screening Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC

Application

The PANA RealTyper™ HPV Screening Kit is an in vitro diagnostic reagent for detecting of human papilloma virus (HPV) from common specimen type, cervical swab and liquid based cytology (LBC) sample. This kit is an amplified DNA test for the qualitative detection of a total of 14 high-risk (HR) HPV types and 2 low-risk (LR) HPV types in a real-time PCR (polymerase chain reaction) system. This kit specially identifies 2 HR types such as 16 and 18 and 2 LR types such as 6 and 11 while concurrently detecting the other HR HPV types that includes 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68.

Other information

▶ Supplier

Panagene

▶ Order Information:

PANARealTyperTM HPV Screening Kit

Code: PNAM-5001

Package: 96 Tests/Kit

Related Products

GeneProof Herpes Simplex Virus (HSV-1/2) PCR Kit

MORE INFORMATION FROM ONE REACTION

  • PCR kit detects and distinguishes Herpes Simplex Virus 1 and Herpes Simplex Virus 2 in a single reaction tube

EXCELLENT QUALITY

  • The highest possible diagnostic sensitivity (100.00%) and diagnostic specificity (97.62%)

SIMPLE LABORATORY WORKFLOW

  • Easily combinable with other GeneProof PCR kits in one workflow

GeneProof Adenovirus PCR Kit

DETECTION OF ALL HUMAN ADENOVIRUS SPECIES

The kit enables detection of Adenovirus respiratory species A–D, G and gastrointestinal species E-F

WIDE RANGE OF VALIDATED CLINICAL MATERIALS

  • Validated specimen: aspirate, plasma, stool, swab, urine, whole blood
  • Enables detection of both respiratory and gastrointestinal samples

Automatic extraction device PANAMAX™ 48

As a product of Panagene (Korea), the PANAMAX ™ 48 automatic extraction device works on the principle of using lysis and binding of samples by magnetic particles. Along with 3 samples kit ready-for-use for the process of extracting DNA/RNA/ccfDNA, this is the solution automatically 100%, just adding the sample to the correct specified wells, the […]

BRCAaccuTest™ & BRCAaccuTest™PLUS

BRCAaccuTest™ & BRCAaccuTest™PLUS is a regent for producing libraries for
analyzing the BRCA ½ genes using the NGS (next-generation sequencing) method,
which analyzes genomic DNA derived from blood or FFPE tissues.

Next Generation Sequencing System – NovaSeq 6000

Model: NovaSeq 6000
Manufacturer: Illumina/USA
– Scalable platform
Match data output, time to results, and price per sample to study needs
– Flexible performance
Configure sequencing method, flow cell type, and read length to support a broad range of applications
– Streamlined operation
Increase lab efficiency with a simplified workflow and reduced hands-on time

Next-Generation Sequencing System – NextSeq 2000

 The NextSeq 2000 Sequencing System uses patterned flow cells similar to those that power the NovaSeq™ 6000 System. The result is a highly flexible and scalable benchtop system that offers the highest cluster density flow cell of any on-market NGS system to date, driving down the cost per gigabase (Gb) of the sequencing run.

NextSeq 1000 sequencing system

Product Information

Model: NextSeq 1000

Manufacturer: Illumina

Origin: Singapore/United States

Launching year: 01/2020

PANARealTyperTM HPV Kit

PANA RealTyperTM HPV Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC.

Next Generation Sequencing System – iSeq 100

Model: iSeq 100
Manufacturer: Illumina/USA
Illumina’s smallest next-generation DNA sequencing system, with small, fast and efficient sequencing throughput, suitable for all labs
– Fast data generation: Suitable for small projects, on a dedicated device, low throughput with fast turnaround times
– Convenient operation: Control the sequencing process from start to finish and ensure independent sequencing instead of outsourcing.

TruSight Cancer Sequencing Panel

Developed with cancer genomics experts in collaboration, oligos ready-to-use, pre-engineered oligos allow researchers to sequence a wide range of genes and single nucleotide polymorphisms (SNPs) in advance. this is related to cancer predisposition